Outbreak of New Mpox Strain in DRC Raises Concerns
- A new strain of the mpox virus has emerged, infecting 130 children in camps surrounding Goma, a key region for aid operations.
- The outbreaks in Goma raise serious concerns about the potential for the virus to spread beyond national borders.
- Health officials are on high alert as this situation may signify a larger public health crisis.
A new strain of mpox has infected approximately 130 children and teenagers in displacement camps near Goma, Democratic Republic of Congo (DRC). The outbreak, which has alarmed health officials, is particularly concerning due to its potential to cross international borders. Local medical professionals report that half of the cases involve children under five years old, highlighting the vulnerability of this population. The charity Medair is actively involved in treating and transporting affected individuals to medical facilities. Health experts, including Dr. Placide Mbala-Kingebeni, have expressed fears that the densely populated camps could lead to a significant outbreak. Mpox spreads through close contact with lesions, and the conditions in these camps are conducive to rapid transmission. The DRC has faced challenges in controlling the outbreak, primarily due to limited resources and interventions. In response to the crisis, a $4.9 million trial is set to assess the safety and efficacy of mpox vaccines in post-exposure scenarios. Dr. Patrick Katoto, leading the trial at the Centre for Tropical Disease and Global Health, emphasized the importance of this research in guiding response strategies and protecting at-risk populations. Additionally, the Coalition for Epidemic Preparedness Innovations (Cepi) is funding a $6.5 million phase two study to evaluate the Bavarian vaccine in children as young as two, aiming to bolster vaccination efforts in endemic regions. The situation remains critical as health authorities work to contain the outbreak and prevent further spread of the virus.